Skip to content

Paragraf announces Innovate UK grant to develop graphene-based diagnostic tool

Paragraf has announced its plan to develop a new generation of graphene-based, in-vitro diagnostic products that will give results within a few minutes.

The Company is starting a two-year program to develop a proof-of-concept combined PCT (procalcitonin) and CRP (C-reactive protein) test, on a single panel. This collaboration utilizes a GBP £550,000 (around USD$658,000) Biomedical Catalyst grant award from Innovate UK, the UK’s innovation agency.

Read More | Graphene-Info
Graphene Sensors, Medicine, Graphene investing and financials, University of Manchester